nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—Respiratory failure—Vandetanib—thyroid cancer	0.0771	0.0771	CcSEcCtD
Butabarbital—Depressed level of consciousness—Vandetanib—thyroid cancer	0.0731	0.0731	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.0393	0.0393	CcSEcCtD
Butabarbital—Bradycardia—Vandetanib—thyroid cancer	0.0387	0.0387	CcSEcCtD
Butabarbital—Loss of consciousness—Vandetanib—thyroid cancer	0.0291	0.0291	CcSEcCtD
Butabarbital—Anxiety—Vandetanib—thyroid cancer	0.0281	0.0281	CcSEcCtD
Butabarbital—Constipation—Vandetanib—thyroid cancer	0.0231	0.0231	CcSEcCtD
Butabarbital—Liver injury—Epirubicin—thyroid cancer	0.0224	0.0224	CcSEcCtD
Butabarbital—Body temperature increased—Vandetanib—thyroid cancer	0.0213	0.0213	CcSEcCtD
Butabarbital—Liver injury—Doxorubicin—thyroid cancer	0.0207	0.0207	CcSEcCtD
Butabarbital—Angioedema—Sorafenib—thyroid cancer	0.0204	0.0204	CcSEcCtD
Butabarbital—Syncope—Sorafenib—thyroid cancer	0.02	0.02	CcSEcCtD
Butabarbital—Loss of consciousness—Sorafenib—thyroid cancer	0.0196	0.0196	CcSEcCtD
Butabarbital—Hepatocellular injury—Epirubicin—thyroid cancer	0.0189	0.0189	CcSEcCtD
Butabarbital—Shock—Sorafenib—thyroid cancer	0.0179	0.0179	CcSEcCtD
Butabarbital—Dizziness—Vandetanib—thyroid cancer	0.0179	0.0179	CcSEcCtD
Butabarbital—Hepatocellular injury—Doxorubicin—thyroid cancer	0.0175	0.0175	CcSEcCtD
Butabarbital—Vomiting—Vandetanib—thyroid cancer	0.0172	0.0172	CcSEcCtD
Butabarbital—Rash—Vandetanib—thyroid cancer	0.017	0.017	CcSEcCtD
Butabarbital—Dermatitis—Vandetanib—thyroid cancer	0.017	0.017	CcSEcCtD
Butabarbital—Headache—Vandetanib—thyroid cancer	0.0169	0.0169	CcSEcCtD
Butabarbital—Nausea—Vandetanib—thyroid cancer	0.016	0.016	CcSEcCtD
Butabarbital—Constipation—Sorafenib—thyroid cancer	0.0156	0.0156	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.0145	0.0145	CcSEcCtD
Butabarbital—Body temperature increased—Sorafenib—thyroid cancer	0.0144	0.0144	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.0134	0.0134	CcSEcCtD
Butabarbital—Hypersensitivity—Sorafenib—thyroid cancer	0.0134	0.0134	CcSEcCtD
Butabarbital—Ataxia—Epirubicin—thyroid cancer	0.0129	0.0129	CcSEcCtD
Butabarbital—Dizziness—Sorafenib—thyroid cancer	0.012	0.012	CcSEcCtD
Butabarbital—Ataxia—Doxorubicin—thyroid cancer	0.0119	0.0119	CcSEcCtD
Butabarbital—Vomiting—Sorafenib—thyroid cancer	0.0116	0.0116	CcSEcCtD
Butabarbital—Rash—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Butabarbital—Dermatitis—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Butabarbital—Headache—Sorafenib—thyroid cancer	0.0114	0.0114	CcSEcCtD
Butabarbital—Nausea—Sorafenib—thyroid cancer	0.0108	0.0108	CcSEcCtD
Butabarbital—Bradycardia—Epirubicin—thyroid cancer	0.00965	0.00965	CcSEcCtD
Butabarbital—Bradycardia—Doxorubicin—thyroid cancer	0.00892	0.00892	CcSEcCtD
Butabarbital—Tension—Epirubicin—thyroid cancer	0.00809	0.00809	CcSEcCtD
Butabarbital—Nervousness—Epirubicin—thyroid cancer	0.00801	0.00801	CcSEcCtD
Butabarbital—Agitation—Epirubicin—thyroid cancer	0.00758	0.00758	CcSEcCtD
Butabarbital—Tension—Doxorubicin—thyroid cancer	0.00749	0.00749	CcSEcCtD
Butabarbital—Nervousness—Doxorubicin—thyroid cancer	0.00741	0.00741	CcSEcCtD
Butabarbital—Syncope—Epirubicin—thyroid cancer	0.0074	0.0074	CcSEcCtD
Butabarbital—Loss of consciousness—Epirubicin—thyroid cancer	0.00725	0.00725	CcSEcCtD
Butabarbital—Agitation—Doxorubicin—thyroid cancer	0.00701	0.00701	CcSEcCtD
Butabarbital—Anxiety—Epirubicin—thyroid cancer	0.007	0.007	CcSEcCtD
Butabarbital—Syncope—Doxorubicin—thyroid cancer	0.00684	0.00684	CcSEcCtD
Butabarbital—Confusional state—Epirubicin—thyroid cancer	0.00679	0.00679	CcSEcCtD
Butabarbital—Loss of consciousness—Doxorubicin—thyroid cancer	0.00671	0.00671	CcSEcCtD
Butabarbital—Shock—Epirubicin—thyroid cancer	0.00662	0.00662	CcSEcCtD
Butabarbital—Anxiety—Doxorubicin—thyroid cancer	0.00647	0.00647	CcSEcCtD
Butabarbital—Hypotension—Epirubicin—thyroid cancer	0.00629	0.00629	CcSEcCtD
Butabarbital—Confusional state—Doxorubicin—thyroid cancer	0.00628	0.00628	CcSEcCtD
Butabarbital—Shock—Doxorubicin—thyroid cancer	0.00613	0.00613	CcSEcCtD
Butabarbital—Somnolence—Epirubicin—thyroid cancer	0.00598	0.00598	CcSEcCtD
Butabarbital—Hypotension—Doxorubicin—thyroid cancer	0.00582	0.00582	CcSEcCtD
Butabarbital—Constipation—Epirubicin—thyroid cancer	0.00576	0.00576	CcSEcCtD
Butabarbital—Feeling abnormal—Epirubicin—thyroid cancer	0.00555	0.00555	CcSEcCtD
Butabarbital—Somnolence—Doxorubicin—thyroid cancer	0.00554	0.00554	CcSEcCtD
Butabarbital—Constipation—Doxorubicin—thyroid cancer	0.00533	0.00533	CcSEcCtD
Butabarbital—Body temperature increased—Epirubicin—thyroid cancer	0.00532	0.00532	CcSEcCtD
Butabarbital—Feeling abnormal—Doxorubicin—thyroid cancer	0.00513	0.00513	CcSEcCtD
Butabarbital—Hypersensitivity—Epirubicin—thyroid cancer	0.00496	0.00496	CcSEcCtD
Butabarbital—Body temperature increased—Doxorubicin—thyroid cancer	0.00492	0.00492	CcSEcCtD
Butabarbital—Hypersensitivity—Doxorubicin—thyroid cancer	0.00459	0.00459	CcSEcCtD
Butabarbital—Dizziness—Epirubicin—thyroid cancer	0.00445	0.00445	CcSEcCtD
Butabarbital—Vomiting—Epirubicin—thyroid cancer	0.00428	0.00428	CcSEcCtD
Butabarbital—Rash—Epirubicin—thyroid cancer	0.00424	0.00424	CcSEcCtD
Butabarbital—Dermatitis—Epirubicin—thyroid cancer	0.00424	0.00424	CcSEcCtD
Butabarbital—Headache—Epirubicin—thyroid cancer	0.00422	0.00422	CcSEcCtD
Butabarbital—Dizziness—Doxorubicin—thyroid cancer	0.00412	0.00412	CcSEcCtD
Butabarbital—Nausea—Epirubicin—thyroid cancer	0.004	0.004	CcSEcCtD
Butabarbital—Vomiting—Doxorubicin—thyroid cancer	0.00396	0.00396	CcSEcCtD
Butabarbital—Rash—Doxorubicin—thyroid cancer	0.00393	0.00393	CcSEcCtD
Butabarbital—Dermatitis—Doxorubicin—thyroid cancer	0.00392	0.00392	CcSEcCtD
Butabarbital—Headache—Doxorubicin—thyroid cancer	0.0039	0.0039	CcSEcCtD
Butabarbital—Nausea—Doxorubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
